|
- IMBRUVICA® (ibrutinib) | Official Patient Website
Find important information about IMBRUVICA® (ibrutinib) uses, dosing, support, and more on the official patient website See full Prescribing Safety Information View the official IMBRUVICA® (ibrutinib) patient website
- IMBRUVICA® Side Effects - CLL SLL | IMBRUVICA® (ibrutinib)
The most common side effects of IMBRUVICA® in adults with B-cell malignancies (CLL SLL and WM) include low platelet count; diarrhea; tiredness; muscle, bone, and joint pain; low white blood cell count; rash; low red blood cell count (anemia); bruising; and nausea
- Taking IMBRUVICA® | IMBRUVICA® (ibrutinib)
Find IMBRUVICA® (ibrutinib) dosing information and helpful tips for adding it to your routine and keeping track of treatments See full Prescribing Safety Information View the official IMBRUVICA® (ibrutinib) patient website
- How Does IMBRUVICA® (ibrutinib) Work?
Learn how IMBRUVICA® works for chronic lymphocytic leukemia treatment and small lymphocytic lymphoma See full Prescribing Safety Information View the official IMBRUVICA® (ibrutinib) patient website
- IMBRUVICA® Side Effects Dosing - WM | IMBRUVICA® (ibrutinib)
View important information about IMBRUVICA® side effects, tips for side effects, and IMBRUVICA® dosage information for WM See full Prescribing Safety Information View the official IMBRUVICA® (ibrutinib) patient website
- CLL and SLL Treatment | IMBRUVICA® (ibrutinib)
Learn about treating chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) with IMBRUVICA® (ibrutinib) See full Prescribing Safety Information View the official IMBRUVICA® (ibrutinib) patient website
- IMBRUVICA® By Your Side | IMBRUVICA® (ibrutinib)
Learn about IMBRUVICA® (ibrutinib) By Your Side, a patient assistance program that provides financial options and support See full Prescribing Safety Information View the official IMBRUVICA® (ibrutinib) patient website
- WM Treatment | IMBRUVICA® (ibrutinib)
Find important information for patients about IMBRUVICA® (ibrutinib), a treatment for waldenström’s macroglobulinemia (WM) See full Prescribing Safety Information View the official IMBRUVICA® (ibrutinib) patient website
|
|
|